Pancreatic Cancer Research

ResearcherNational and Kapodistrian University of AthensActive in the last 2 years

Dimitriοs Schizas

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-7046-0112; OpenAlex author ID A5069496420. Sources: OpenAlex.

Their work

Papers
15 (first author 1, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
28
Papers, trials and grants by year

2020: 1 paper · 2021: 6 papers · 2022: 3 papers · 2023: 1 paper · 2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 15

  1. International survey on neoadjuvant treatments in anatomically resectable pancreatic adenocarcinoma (INSPIRA): a real-life snapshot. Co-author DOI 10.1016/j.suronc.2026.102580↗
  2. Emerging Tumor Biomarkers in Pancreatic Cancer and Their Clinical Implications. Co-author DOI 10.3390/cimb47050347↗
  3. Exploring the Link Between Nutritional and Functional Status and Short-Term Postoperative Outcomes in Patients Undergoing Pancreatic Cancer Surgery. Last author DOI 10.3390/life15050803↗
  4. Significance of TP53, CDKN2A, SMAD4 and KRAS in Pancreatic Cancer. Co-author DOI 10.3390/cimb46040177↗
  5. "Oligometastatic pancreatic cancer" definition: The first step. First author DOI 10.1016/j.hbpd.2022.07.002↗
  6. The impact of surgery delay on survival of resectable pancreatic cancer: A systematic review of observational studies. Co-author DOI 10.1016/j.suronc.2022.101855↗
  7. Surgical management of familial pancreatic cancer: a systematic review of the literature. Last author DOI 10.1111/ans.17834↗
  8. Immunotherapy in Combination with Well-Established Treatment Strategies in Pancreatic Cancer: Current Insights. Last author DOI 10.2147/cmar.s267260↗
  9. The Impact of Cirrhosis on Pancreatic Cancer Surgery: A Systematic Review and Meta-Analysis. Co-author DOI 10.1007/s00268-020-05821-7↗
  10. Irreversible Electroporation (IRE) Combined With Chemotherapy Increases Survival in Locally Advanced Pancreatic Cancer (LAPC). Co-author DOI 10.1097/coc.0000000000000826↗
  11. Combinatorial Treatment of Tinzaparin and Chemotherapy can Induce a Significant Antitumor Effectin Pancreatic Cancer Co-author DOI 10.21203/rs.3.rs-551892/v1↗
  12. A personalized approach to pancreatic ductal adenocarcinoma and its application in surgical practice. Co-author DOI 10.2217/pme-2021-0031↗
  13. The Impact of Thromboprophylaxis on the Survival of Patients with Advanced Pancreatic Cancer. The Pancreatic Cancer and Tinzaparin (PaCT) Study. Co-author DOI 10.3390/cancers13122884↗
  14. Combinatorial Treatment of Tinzaparin and Chemotherapy Can Induce a Significant Antitumor Effect in Pancreatic Cancer. Co-author DOI 10.3390/ijms22137053↗
  15. Immunotherapy for pancreatic cancer: A 2020 update. Co-author DOI 10.1016/j.ctrv.2020.102016↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maximos Frountzas · 6 shared papers, 2022–2025 · strength 1.40
  2. Konstantinos G. Toutouzas · 5 shared papers, 2022–2025 · strength 1.22
  3. Evangelos S. Felekouras · 7 shared papers, 2021–2025 · strength 0.96
  4. Dimitrios Stefanoudakis · 3 shared papers, 2024–2025 · strength 0.78
  5. Michail G. Vailas · 4 shared papers, 2021–2025 · strength 0.68
  6. Michalis V. Karamouzis · 5 shared papers, 2020–2021 · strength 0.59
  7. Alexandros Papalampros · 4 shared papers, 2021 · strength 0.48
  8. Evangelos Koustas · 3 shared papers, 2020–2021 · strength 0.36
  9. Pavlos Papakotoulas · 3 shared papers, 2021 · strength 0.36
  10. Panagiotis Sarantis · 3 shared papers, 2021 · strength 0.36
  11. Christo Kole · 2 shared papers, 2020–2022 · strength 0.30
  12. Maria G Sotiropoulou · 2 shared papers, 2021–2022 · strength 0.29
  13. Alexandra Drakaki · 1 shared paper, 2024 · strength 0.26
  14. Dimitrios Moris · 2 shared papers, 2021 · strength 0.25
  15. Stamatios E Theocharis · 2 shared papers, 2021 · strength 0.25
  16. Athanasios G. Papavassiliou · 2 shared papers, 2021 · strength 0.25
  17. Irene Lidoriki · 1 shared paper, 2025 · strength 0.22
  18. Dimitrios K Filippou · 1 shared paper, 2022 · strength 0.16
  19. George Bagias · 1 shared paper, 2022 · strength 0.16
  20. Konstantinos P. Toutouzas · 1 shared paper, 2021 · strength 0.13
  21. Athanasios S. Petrou · 1 shared paper, 2021 · strength 0.12
  22. Dimitrios Oikonomou · 1 shared paper, 2021 · strength 0.12
  23. Nikolaos Dimitrokallis · 1 shared paper, 2021 · strength 0.12
  24. Demetris Papamichael · 1 shared paper, 2021 · strength 0.12
  25. Dimitrios C. Ziogas · 1 shared paper, 2020 · strength 0.11

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.